Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
WSTWest Pharmaceutical Services
FinDog View：Neutral
| Metric | TMO | WST |
|---|
| Close | 648.43 | 362.01 |
| Market Cap | $240B | $23.9B |
| 1M | +10.75% | +4.44% |
| P/E (TTM) | 34.4 | 43.1 |
| Forward P/E | 21.8 | 36.0 |
| P/E 5-Yr Percentile | 65 | 49 |
| P/S | 5.2 | 7.3 |
| P/B | 4.6 | 8.2 |
| Dividend Yield | 0.29% | 0.33% |
| Latest Quarter Revenue | $12.0B | $872M |
| Revenue YoY | +10.5% | +13.8% |
| Gross Margin | — | 37.7% |
| Latest Quarter EPS | 4.68 | 2.15 |
| Avg Post-Earnings Move | ±1.2% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.36% | 2.16% |
| 90-Day Net Insider Buying | −$38.9M | −$5.4M |
TMO · Revenue, Last 8 Quarters ($B)
WST · Revenue, Last 8 Quarters ($B)
